https://www.selleckchem.com/Bcl-2.html
This is a double blind phase II/III placebo-controlled randomized trial of the safety and efficacy of GH treatment in incomplete chronic traumatic spinal cord injury. The aim of this study was to investigate the possibility to use exogenous GH administration for motor recovery in chronic traumatic incomplete human SCI. The objectives were to establish safety and efficacy of a combined treatment of subcutaneous GH (or placebo) and rehabilitation in this population. Hospital Nacional de Parapléjicos METHODS The pharmacological treatment was a subcut
Like
Comment
Share
